From: Morris, Evan [EMorris@PattonBoggs.com]
Sent: Tuesday, July 06, 2004 4:03 PM
To: fdadockets@oc.fda.gov
Subject: Docket No. 2004S-0170

Jennie,

Per my earlier conversation with Ryan Cleaver, attached please find Pfizer's comments for Docket No. 2004S-0170.  Ryan indicated that you would accept these comments via e-mail.  

Thank you for your assistance,

Evan Morris
Patton Boggs, LLP
202-457-6556


DISCLAIMER:
This e-mail message contains confidential, privileged information intended solely for the addressee.  Please do not read, copy, or disseminate it unless you are the addressee.  If you have received it in error, please call us (collect) at (202) 457-6000 and ask to speak with the message sender.  Also, we would appreciate your forwarding the message back to us and deleting it from your system.  Thank you.

This e-mail and all other electronic (including voice) communications from the sender's firm are for informational purposes only.  No such communication is intended by the sender to constitute either an electronic record or an electronic signature, or to constitute any agreement by the sender to conduct a transaction by electronic means.  Any such intention or agreement is hereby expressly disclaimed unless otherwise specifically indicated.  To learn more about our firm, please visit our website at http://www.pattonboggs.com.